Stabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature
The DOI matches its Crossref record.
Abstract
Management of bipolar disorder has traditionally emphasized the acute treatment of mania. Although acute treatment of mania is a critical aspect of care, this emphasis has tended to overshadow other important phases of bipolar disorder, such as depression, hypomania, and subsyndromal symptoms. We offer a reconceptualization of bipolar disorder that highlights unmet needs and the importance of differential spectra of efficacy. In this reconceptualization, bipolar disorder can be viewed as an aberration of mood, behavior, and cognition from baseline (euthymia). "Below baseline" is characterized by depression and subsyndromal depression. "Above baseline" is characterized by mania, mixed states, hypomania, and subsyndromal mood elevation. In contrast to the treatment options for mania, the options for depression are limited. This new nomenclature emphasizes the need to develop mood stabilizers that possess the ability to stabilize mood "from below baseline," either alone or in combination with other agents. In this article, the treatment options for bipolar disorder, with a focus on depression and rapid cycling, are discussed according to this new conceptualization of management from below and above baseline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Responders to lamotrigine have a predominantly depressive polarity as well as comorbid anxiety.420, 421”
Citations
Cites
Still being checked.
Cited by
Items 101–162 of 162
Born, C., Bernhard, B., Dittmann, S., Seemüller, F., & Grunze, H. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.020 · Cited by 15
Ketter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 15
Self-citationThe efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting
Dennehy, E. B., Doyle, K., & Suppes, T. M. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200305000-00003 · Cited by 13
Bipolar Drug Development: Are We Getting Closer to the Real World?
Calabrese, J. R., & Kemp, D. E. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08060967 · Cited by 12
Self-citationThe treatment of bipolar mixed states
Cookson, J., & Ghalib, S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.016 · Cited by 11
Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Holland, A. A., Nam, J. Y., Culver, J. L., Marsh, W., & Bonner, J. C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.005 · Cited by 13
Self-citationOlanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M. R., Das, B., Santosa, C. M., Mongkolcheep, J., & Ketter, T. A. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01210.x · Cited by 10
Self-citationBipolar (Manic Depressive) Disorders
El‐Mallakh, R. S., & Bauer, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch49 · Cited by 10
Lei, D., Li, W., Tallman, M. J., Strakowski, S. M., DelBello, M. P., Patino, L. R., Fleck, D. E., Lui, S., Gong, Q., Sweeney, J. A., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01328-y · Cited by 9
What Drugs Are Best for Bipolar Depression?
Baldassano, C. F., Datto, S. M., Littman, L., & Lipari, M. A. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008176.32677.32 · Cited by 9
Mood-Stabilizing Properties of Lamotrigine: A Review of Data from Controlled Clinical Trials
Leadbetter, R. A., Messenheimer, J. A., Bentley, B., Greene, P., Huffman, R., & Spaulding, T. C. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20021201-12 · Cited by 8
Open-Label, Concomitant Use of Lamotrigine and Other Medications for Bipolar Disorder
Bowden, C. L., Edwards, S., & Evoniuk, G. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900016187 · Cited by 7
Clozapine augmentation for treatment-resistant schizoaffective disorder
Lally, J., Tully, J., & MacCabe, J. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012104 · Cited by 7
Depression mood stabilisation: novel concepts and clinical management
Calabrese, J. R. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.03.002 · Cited by 7
Self-citationPal, A. (2019) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_216_18 · Cited by 6
Extra-synaptic modulation of GABAA and efficacy in bipolar disorder
El‐Mallakh, R. S., & Ali, Z. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110501 · Cited by 6
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 9
Self-citationThe challenges of pharmacotherapy of bipolar depression
Thase, M. E., & Sachs, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00045-2 · Cited by 5
The Emerging Role of Olanzapine in Bipolar Disorders
Ketter, T. A., Wang, P. W., Janenawasin, S., Becker, O. V., & Wang, A. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20021201-10 · Cited by 5
Self-citationWhat psychotherapists should know about pharmacotherapies for bipolar disorder
Goldberg, J. F. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20362 · Cited by 4
The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action
Amann, B. L., & Grunze, H. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.1.107 · Cited by 4
Novel experimental and early investigational drugs for the treatment of bipolar disorder
Carta, M. G., Kalcev, G., Fornaro, M., & Nardi, A. E. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.2000965 · Cited by 3
Hussain, A., Shah, M. S., Roub, F. E., Dar, M. A., Wani, Z. A., Jan, M. M., Wani, R. A., & Bhat, T. A. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.162916 · Cited by 3
Nomenklatur, Einteilung von Psychopharmaka
Laux, G. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_7 · Cited by 3
Ali, D. N., Campbell, I. H., Leung, J. G., González-Campos, T., Liu, D., Ercis, M., Markota, M., Ceylan, D., Lara-Breitinger, K. M., López-Jiménez, F. A., et al. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100616 · Cited by 3
Obsessive-Compulsive Symptoms in Schizophrenia
Poyurovsky, M. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190228163.003.0057 · Cited by 4
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal
Goldberg, J. F. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23ac15219 · Cited by 2
Management of Bipolar II Disorder
Parker, G. B., & Ketter, T. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch26 · Cited by 2
Self-citationLes médicaments thymorégulateurs et leurs associations dans le traitement des troubles bipolaires
Bourgeois, M. L. (2004) · PSN · doi:10.1007/bf03005210 · Cited by 2
Beneficial effect of digoxin-specific Fab fragments in bipolar disorder- a preliminary study
Zilberstein, A., Krivoy, N., Horesh, N., Klein, E., & Lichtstein, D. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100600 · Cited by 2
Mood Stabilizers and Novel Antipsychotics in the Treatment of Borderline Personality Disorder
Bellino, S., Paradiso, E., & Bogetto, F. (2006) · Institutional Research Information System University of Turin (University of Turin) · Cited by 2
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., Greil, W., & von Stralendorff, I. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50013-7 · Cited by 1
Bauer, M., Severus, E., & Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_68 · Cited by 1
Chapter 39. Carbamazepine, Oxcarbazepine, and Eslicarbazepine
Post, R. M., Wang, P. W., & Ketter, T. A. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as39 · Cited by 1
Self-citationLaux, G., & Dietmaier, O. (2006) · Elsevier eBooks · doi:10.1016/b978-343721063-1.50025-1
Stimmungsstabilisierer (Phasenprophylaktika)
Laux, G., & Dietmaier, O. (2006) · Elsevier eBooks · doi:10.1016/b978-343721063-1.50037-8
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Biological treatments for psychotic disorders
Girgis, R. R., Schobel, S., & Lieberman, J. A. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.027
Benkert, O., Hautzinger, M., Graf-Morgenstern, M., Paulzen, M., & Himmerich, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-49092-1_15
ANTIDEPRESSANT ACTIVITY OF MOOD STABILIZERS
RYBAKOWSKI, J. K. (2012)
La Quetiapina nel trattamento della depressione bipolare
Camilleri, V., & Mauri, M. C. (2005) · CINECA IRIS Institutial research information system (University of Pisa)
Marcadores biológicos e nível de funcionalidade em pacientes bipolares
Rosa, A. R. (2007) · Lume (Universidade Federal do Rio Grande do Sul)
Therapeutic Approaches to Bipolar Disorder
Ahmad, M. U., Ali, S. M., Sheikh, S., Ahmad, A., & Ahmad, I. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00333
Medication treatment of mania: Acute and preventive
Kahn, D. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.008
Pharmacogenetics of Mood Stabilizers
RYBAKOWSKI, J. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-27040-1_6
Laux, G., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_56
Donald, A. (2016) · Summit (Simon Fraser University)
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., Greil, W., WINKLER, R., & SCHMIDT, D. (2006) · Elsevier eBooks · doi:10.1016/b978-343724130-7.50010-9
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., WINKLER, R., Greil, W., & GIERSCH, D. (2007) · Elsevier eBooks · doi:10.1016/b978-343724131-4.50013-5
Psicoeducación: mejorar la evolución en el trastorno bipolar
Colom, F., & Lam, D. H. (2006) · European psychiatry (Ed Española) · doi:10.1017/s1134066500002903
Sinclair, J. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500500360676
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21064-8.16001-5
Lam, D. H., Jones, S. H., & Hayward, P. (2010) · Wiley eBooks · doi:10.1002/9780470970256.refs
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_56
Bauer, M., Severus, E., & Laux, G. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_68-1
Goldberg, J. F. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.023
Goldberg, J. F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.026
Overview of Management Options
Vieta, E. (2013) · doi:10.1007/978-1-908517-94-4_6
Network-specific Cerebellar-Cortical Connectivity Alterations in Bipolar Disorder and Schizophrenia
Kim, M. (2021) · NORA - Norwegian Open Research Archives
Ketamine for Bipolar Depression
Fancy, F. (2024) · TSpace (University of Toronto)
Mood destabilizers?: A review of mood stabilizer-associated mania
Schwartz, S. E., Hundley, A. M., Chan, C. Y. M., & Baalmann, A. R. (2026) · Pharmacopsychiatry · doi:10.1055/a-2934-0429
Hausmann, A., Strauss, R., Weiss, U., & Conca, A. (2005) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-005-0012-8
Metadata
- Authors
- Ketter, T., & Calabrese, J. R.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-02-15
- Volume
- 63
- Issue
- 2
- Pages
- 146-151
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2046597861
- Cited by
- 161
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 1 · 2013: 8 · 2012: 6
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- bipolar disorder, mood stabilization, euthymia, depression, subthreshold depression, mania, hypomania, mixed states, rapid cycling, mood stabilizers
- MeSH terms
- Lamotrigine, Affect, Antidepressive Agents, Bipolar Disorder, Carbamazepine, Clinical Trials as Topic, Double-Blind Method, Electroconvulsive Therapy, Humans, Lithium, Models, Psychological, Terminology as Topic, Antipsychotic Agents, Triazines, Valproic Acid, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.